URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

John Bisognano

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentMedicine
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 679-7
Rochester NY 14642
Other Positions
TitleDirector, Outpatient Cardiology Services
InstitutionSchool of Medicine and Dentistry
DepartmentMedicine
DivisionMedicine - Cardiology

 
 Overview
Dr. Bisognano is a Professor of Medicine and Director of Cardiac Rehabilitation and Clinical Preventive Cardiology. He joined the faculty in September 2001 from the University of Michigan where he participated in the Hypertension and Vascular Medicine Program as well as the Heart Failure and Transplantation Program.

Dr. Bisognano's research focuses on cardiovascular risk factor reduction, with a particular interest on improving compliance with the national guidelines for the treatment of hypertension. He is also interested in the etiology of hypertensive urgencies and emergencies, including the development of evidence-based treatment protocols for office patients with severely elevated blood pressure but no evidence of ongoing target organ damage. Additionally, he is interested in a community-based education program in the evaluation and treatment of hypertension, noting that only a small fraction of patients with hypertension achieve the blood pressure goals suggested by the national guidelines.

Dr. Bisognano is Upstate Governor for the New York American College of Cardiology through March 31, 2012. He is also the President, of the New York Cardiological Society, effective September 30, 2010 – March 31, 2012, and the President of theNew York Chapter, American College of Cardiology, present to September 30, 2010 through March 31, 2012.

 
 Selected Publications
  • Lien SF, Bisognano JD. Perioperative hypertension: defining at-risk patients and their management. Curr Hypertens Rep. 2012 Oct; 14(5):432-41.
    View in: PubMed
  • Davidson AC, Bisognano JD. Interventional approaches for resistant hypertension. Curr Opin Nephrol Hypertens. 2012 Sep; 21(5):475-80.
    View in: PubMed
  • Gassler JP, Lynch PS, Bisognano JD. The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension. Heart. 2012 Dec; 98(23):1689-92.
    View in: PubMed
  • Woolf KJ, Zabad MN, Post JM, McNitt S, Williams GC, Bisognano JD. Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. Am J Cardiol. 2012 Oct 1; 110(7):968-70.
    View in: PubMed
  • Rich DQ, Zareba W, Beckett W, Hopke PK, Oakes D, Frampton MW, Bisognano J, Chalupa D, Bausch J, O'Shea K, Wang Y, Utell MJ. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environ Health Perspect. 2012 Aug; 120(8):1162-9.
    View in: PubMed
  • Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens. 2012 Mar; 6(2):152-8.
    View in: PubMed
  • Bisognano JD, Speranza PS, Becker LM, Norwood WS, Bradley A, Nazar MD, Beckman HB. Creating community collaboration to improve the care of patients with high blood pressure: lessons from Rochester, new york. J Clin Hypertens (Greenwich). 2012 Mar; 14(3):178-83.
    View in: PubMed
  • Woolf KJ, Bisognano JD. Nondrug interventions for treatment of hypertension. J Clin Hypertens (Greenwich). 2011 Nov; 13(11):829-35.
    View in: PubMed
  • Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011 Aug 9; 58(7):765-73.
    View in: PubMed
  • Bisognano JD, Kaufman CL, Bach DS, Lovett EG, de Leeuw P. Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system. J Am Coll Cardiol. 2011 Apr 26; 57(17):1787-8.
    View in: PubMed
  • Gewirtz JR, Bisognano JD. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension. Cardiol J. 2011; 18(1):97-102.
    View in: PubMed
  • Taylor JG, Bisognano JD. Baroreflex stimulation in antihypertensive treatment. Curr Hypertens Rep. 2010 Jun; 12(3):176-81.
    View in: PubMed
  • McClintic BR, McClintic JI, Bisognano JD, Block RC. The relationship between retinal microvascular abnormalities and coronary heart disease: a review. Am J Med. 2010 Apr; 123(4):374.e1-7.
    View in: PubMed
  • Bergset J, Storozynsky E, Bisognano JD. Renin inhibition for hypertension: selecting the right role for a new class of drug. Am J Ther. 2010 Mar-Apr; 17(2):182-7.
    View in: PubMed
  • Nelson R, Antonetti I, Bisognano JD, Sloand J. Obesity-related cardiorenal syndrome. J Clin Hypertens (Greenwich). 2010 Jan; 12(1):59-63.
    View in: PubMed
  • Baker ML, Wormer D, Bisognano JD. Thromboembolic events of mitral valve endocarditis. Cardiol J. 2010; 17(2):192-3.
    View in: PubMed
  • Aung T, Bisognano JD, Morgan MA. Allergic respiratory disease as a potential co-morbidity for hypertension. Cardiol J. 2010; 17(5):443-7.
    View in: PubMed
  • Rao M, Rajda G, Uppuluri S, Beck GR, Liu L, Bisognano JD. The role of continuous positive airway pressure in the treatment of hypertension in patients with obstructive sleep apnea-hypoapnea syndrome: a review of randomized trials. Rev Recent Clin Trials. 2010 Jan; 5(1):35-42.
    View in: PubMed
  • Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009 Oct; 122(10):890-5.
    View in: PubMed
  • Young KC, Teeters JC, Benesch CG, Bisognano JD, Illig KA. Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator. J Clin Hypertens (Greenwich). 2009 Oct; 11(10):555-63.
    View in: PubMed
  • Ban-Hoefen M, Bernstein SH, Bisognano JD, Pryor JG, Friedberg JW. Symptomatic intracardiac diffuse large B-cell lymphoma. Am J Hematol. 2009 Oct; 84(10):683-5.
    View in: PubMed
  • Gassler JP, Bisognano JD. Commentary: revisiting the early morning blood pressure surge and myocardial ischemia. J Clin Hypertens (Greenwich). 2009 Jul; 11(7):348-50.
    View in: PubMed
  • Zareba KM, Shenkman HJ, Bisognano JD. Comparison of acute electrocardiographic presentation in patients with diastolic vs systolic heart failure. Congest Heart Fail. 2009 Jul-Aug; 15(4):165-9.
    View in: PubMed
  • Joshi N, Taylor J, Bisognano JD. Implantable device therapy for the treatment of resistant hypertension. J Cardiovasc Transl Res. 2009 Jun; 2(2):150-3.
    View in: PubMed
  • Azzara CD, Nickels MW, Bisognano JD. Labile hypertension: lessons to be learned from musical improvisation. J Clin Hypertens (Greenwich). 2009 Mar; 11(3):113-5.
    View in: PubMed
  • Jindal V, Baker ML, Aryangat A, Wittlin SD, Bisognano JD, Richter HS. Pheochromocytoma: presenting with regular cyclic blood pressure and inverted Takotsubo cardiomyopathy. J Clin Hypertens (Greenwich). 2009 Feb; 11(2):81-6.
    View in: PubMed
  • Uppuluri SC, Storozynsky E, Bisognano JD. Baroreflex device therapy in the treatment of hypertension. Curr Hypertens Rep. 2009 Feb; 11(1):69-75.
    View in: PubMed
  • Hong JA, Bisognano JD. Metoprolol succinate therapy associated with erythema multiforme. Cardiol J. 2009; 16(1):82-3.
    View in: PubMed
  • Zeglin MA, Pacos J, Bisognano JD. Hypertension in the very elderly: Brief review of management. Cardiol J. 2009; 16(4):379-85.
    View in: PubMed
  • Navaneethan SD, Lohmeier TE, Bisognano JD. Baroreflex stimulation: A novel treatment option for resistant hypertension. J Am Soc Hypertens. 2009 Jan-Feb; 3(1):69-74.
    View in: PubMed
  • Dockery BK, Bisognano JD. Direct renin inhibition: an analysis of possible benefits. Curr Hypertens Rep. 2008 Aug; 10(4):313-8.
    View in: PubMed
  • Zareba KM, Shenkman HJ, Bisognano JD. Predictive value of admission electrocardiography in patients with heart failure. Congest Heart Fail. 2008 Jul-Aug; 14(4):173-9.
    View in: PubMed
  • Maki KC, Curry LL, Carakostas MC, Tarka SM, Reeves MS, Farmer MV, McKenney JM, Toth PD, Schwartz SL, Lubin BC, Dicklin MR, Boileau AC, Bisognano JD. The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure. Food Chem Toxicol. 2008 Jul; 46 Suppl 7:S40-6.
    View in: PubMed
  • Ban-Hoefen M, Zeglin MA, Bisognano JD. Diffuse large B cell lymphoma presenting as a cardiac mass and odynophagia. Cardiol J. 2008; 15(5):471-4.
    View in: PubMed
  • Sloand JA, Illig KA, Bisognano JD. Improved control of resistant hypertension with device-mediated electrical carotid sinus baroreflex stimulation. J Clin Hypertens (Greenwich). 2007 Sep; 9(9):716-9.
    View in: PubMed
  • Filippone JD, Bisognano JD. Baroreflex stimulation in the treatment of hypertension. Curr Opin Nephrol Hypertens. 2007 Sep; 16(5):403-8.
    View in: PubMed
  • Sloand JA, Bisognano JD. Vascular disease in an expanding world: seeking answers inside and outside of the box. J Clin Hypertens (Greenwich). 2007 Apr; 9(4):246-8.
    View in: PubMed
  • Shenkman HJ, Zareba W, Bisognano JD. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure. Am J Cardiol. 2007 Apr 15; 99(8):1143-5.
    View in: PubMed
  • Bisognano JD, Townsend KA, Skyles AJ, Samuels KM. Prevalence of comorbidities and their influence on blood pressure goal attainment in geriatric patients. Am J Geriatr Cardiol. 2007 Jan-Feb; 16(1):24-9.
    View in: PubMed
  • Sloand JA, Balakrishnan SL, Fong MW, Bisognano JD. Evaluation and treatment of resistant hypertension. Cardiol J. 2007; 14(4):329-30.
    View in: PubMed
  • Fong MW, Filippone JD, Beck GR, Katz MG, Bisognano JD. Improving care in resistant hypertension: medication trends and nonpharmacologic strategies in a specialty clinic. Am J Cardiovasc Drugs. 2007; 7(6):449-52.
    View in: PubMed
  • Bisognano JD, McLaughlin T, Roberts CS, Tang SS. Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension. Vasc Health Risk Manag. 2007; 3(5):579-85.
    View in: PubMed
  • Filippone JD, Sloand JA, Illig KA, Bisognano JD. Electrical stimulation of the carotid sinus for the treatment of resistant hypertension. Curr Hypertens Rep. 2006 Oct; 8(5):420-4.
    View in: PubMed
  • Moser M, Izzo JL, Bisognano J. Hypertensive emergencies. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):275-81.
    View in: PubMed
  • Vorobiof G, Blaxall BC, Bisognano JD. The future of endothelin-receptor antagonism as treatment for systemic hypertension. Curr Hypertens Rep. 2006 Apr; 8(1):35-44.
    View in: PubMed
  • Bender SR, Fong MW, Heitz S, Bisognano JD. Characteristics and management of patients presenting to the emergency department with hypertensive urgency. J Clin Hypertens (Greenwich). 2006 Jan; 8(1):12-8.
    View in: PubMed
  • Bisognano JD, McGrody KS, Spence AM. Myocarditis from the Chinese sumac tree. Ann Intern Med. 2005 Jul 19; 143(2):159-60.
    View in: PubMed
  • Hill MD, Bisognano JD. Leukoaraiosis: the brain under pressure: target for treatment? Neurology. 2005 Jun 14; 64(11):1832-3.
    View in: PubMed
  • Bisognano JD, Lindenfeld J, Hammond E, Zisman LS. Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient. J Heart Lung Transplant. 2005 Mar; 24(3):355-8.
    View in: PubMed
  • Berk BC, Bisognano JD. VALUE in hypertension treatment. Curr Hypertens Rep. 2004 Dec; 6(6):411-3.
    View in: PubMed
  • Valentini M, Julius S, Palatini P, Brook RD, Bard RL, Bisognano JD, Kaciroti N. Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens. 2004 Oct; 22(10):1999-2006.
    View in: PubMed
  • Bisognano J, McLaughlin T, Roberts CS, Battleman D, Schwartz B, Garza D, Tang S. Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens. Am J Hypertens. 2004 Aug; 17(8):676-83.
    View in: PubMed
  • Majahalme SK, Smith DE, Cooper JV, Kline-Rogers E, Mehta RH, Eagle KA, Bisognano JD. Comparison of patients with acute coronary syndrome with and without systemic hypertension. Am J Cardiol. 2003 Aug 1; 92(3):258-63.
    View in: PubMed
  • Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 2000 May; 32(5):817-30.
    View in: PubMed
  • Bisognano JD, Cody RJ. The renin-angiotensin system antagonism in the treatment of hypertension. Curr Hypertens Rep. 1999 Aug; 1(4):275-7.
    View in: PubMed
  • Bisognano JD, Morgan MB, Lowes BD, Wolfel EE, Lindenfeld J, Zisman LS. Acute parvovirus infection in a heart transplant recipient. Transplant Proc. 1999 Aug; 31(5):2159-60.
    View in: PubMed
  • Bisognano JD, Weder AB. Effective treatment of severe hypertension. Prog Cardiovasc Nurs. 1999; 14(4):150-2, 158.
    View in: PubMed
  • Bisognano JD, Merrick DT, Popylisen SL, Hoffman MS, Weinberger HD. Congenital duplication of the tricuspid valve presenting as a circumscribed obstructive mass in the right ventricular outflow tract. J Am Soc Echocardiogr. 1998 May; 11(5):480-2.
    View in: PubMed
  • Bisognano JD, Horwitz LD. Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension. West J Med. 1998 Apr; 168(4):272-4.
    View in: PubMed
  • Bisognano JD, Young B, Brown JM, Gill EA, Fang FC, Zisman LS. Diverse presentation of aberrant origin of the right subclavian artery: two case reports. Chest. 1997 Dec; 112(6):1693-7.
    View in: PubMed
  • Pende A, Tremmel KD, DeMaria CT, Blaxall BC, Minobe WA, Sherman JA, Bisognano JD, Bristow MR, Brewer G, Port J. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem. 1996 Apr 5; 271(14):8493-501.
    View in: PubMed
  • Freedman JC, Novak TS, Bisognano JD, Pratap PR. Voltage dependence of DIDS-insensitive chloride conductance in human red blood cells treated with valinomycin or gramicidin. J Gen Physiol. 1994 Nov; 104(5):961-83.
    View in: PubMed
  • Bisognano JD, Dix JA, Pratap PR, Novak TS, Freedman JC. Proton (or hydroxide) fluxes and the biphasic osmotic response of human red blood cells. J Gen Physiol. 1993 Jul; 102(1):99-123.
    View in: PubMed

Visualizations


Bisognano's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department